PEPG
PepGen Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.30
−4.77%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.28
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +18.7%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.28 | -$0.26 | Beat 8.60% | — |
| May 12, 2026 | -$0.31 | -$0.26 | Beat 16.13% | — |
| Mar 4, 2026 | -$0.40 | -$0.27 | Beat 32.50% | — |
| Nov 12, 2025 | -$0.63 | -$0.52 | Beat 17.46% | — |
| Aug 7, 2025 | -$0.85 | -$0.70 | Beat 17.65% | — |
| May 8, 2025 | -$0.72 | -$0.92 | Miss -27.78% | — |
| Nov 7, 2024 | -$0.87 | -$0.66 | Beat 24.14% | — |
| Aug 8, 2024 | -$0.72 | -$0.87 | Miss -20.83% | — |
| Mar 6, 2024 | -$1.01 | -$0.82 | Beat 18.81% | $1.7M |
| May 11, 2023 | -$0.79 | -$0.69 | Beat 12.66% | — |
| Mar 23, 2023 | -$0.87 | -$0.96 | Miss -10.34% | — |
| Nov 10, 2022 | -$1.00 | -$0.79 | Beat 21.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026